Abstract
To examine the impact of seminal vesicle invasion (SVI) in patients with locally advanced (pT3) prostate cancer on clinical outcome. To explore the clinical association of SVI with metastatic disease. To distinguish between the possibilities that either seminal vesicles possess their own biological significance and represent a privileged staging site for systemic tumour cell dissemination, or that their invasion is a surrogate marker for an aggressive large-volume poorly differentiated cancer.
Original language | English |
---|---|
Pages (from-to) | 58 - 63 |
Number of pages | 6 |
Journal | BJU International |
Volume | 110 |
Issue number | Supp 4 |
DOIs | |
Publication status | Published - 2012 |